Evidence map›Paper›PMID 25253985›Full record

ArticleMolecular vision2014

Bone morphogenetic protein 7 regulates reactive gliosis in retinal astrocytes and Müller glia.

Subramanian Dharmarajan, Zafer Gurel, Shoujian Wang, Christine M Sorenson, Nader Sheibani, Teri L Belecky-Adams

Open access · greenAbstract read
In one paragraph

Article in Molecular vision, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Subramanian DharmarajanDepartment of Biology, Indiana University-Purdue University Indianapolis,, Indianapolis, IN ; Center for Regenerative Biology and Medicine, Indiana University- Purdue University Indianapolis, Indianapolis, IN.
Zafer GurelDepartment of Ophthalmology and Visual Sciences, University of Wisconsin School of Medicine and Public Health, Madison, WI.
Shoujian WangDepartment of Ophthalmology and Visual Sciences, University of Wisconsin School of Medicine and Public Health, Madison, WI.
Christine M SorensonDepartment of Pediatrics, University of Wisconsin School of Medicine and Public Health, Madison, WI ; McPherson Eye Research Institute, University of Wisconsin School of Medicine and Public health, Madison, WI.
Nader SheibaniDepartment of Ophthalmology and Visual Sciences, University of Wisconsin School of Medicine and Public Health, Madison, WI ; McPherson Eye Research Institute, University of Wisconsin School of Medicine and Public health, Madison, WI.
Teri L Belecky-AdamsDepartment of Biology, Indiana University-Purdue University Indianapolis,, Indianapolis, IN ; Center for Regenerative Biology and Medicine, Indiana University- Purdue University Indianapolis, Indianapolis, IN.
University of Indianapolis · USUniversity of Wisconsin–Madison · US

Funding

UW COMPREHENSIVE CANCER CENTER SUPPORTP30CA014520 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI Christian Capitini · 1985 to 2026
$142.6M
UW Vision Research Core - Administrative CoreP30EY016665 · NEI · UNIVERSITY OF WISCONSIN-MADISON · PI Donna M Peters · 2005 to 2026
$12.6M
Novel Antiangiogenic Peptides for Treatment of Exudative AMDR24EY022883 · NEI · UNIVERSITY OF WISCONSIN-MADISON · PI SHEIBANI, NADER · 2013 to 2017
$6.2M
Integrated Multidisciplinary Strategies for Detection of Diabetic RetinopathiesRC4EY021357 · NEI · UNIVERSITY OF WISCONSIN-MADISON · PI ASSADI, AMIR H, ASSADI-PORTER, FARIBA M · 2010 to 2010
$3.2M
Astrocyte Development and Reactive GliosisR01EY019525 · NEI · INDIANA UNIVERSITY INDIANAPOLIS · PI BELECKY-ADAMS, TERI L · 2009 to 2012
$1.2M
Bcl-2 and ocular neovascularizationR21EY023024 · NEI · UNIVERSITY OF WISCONSIN-MADISON · PI SORENSON, CHRISTINE M · 2013 to 2014
$410k
Mechanisms of Astrocyte DevelopmentR15EY020816 · NEI · INDIANA UNIVERSITY INDIANAPOLIS · PI BELECKY-ADAMS, TERI L · 2010 to 2010
$376k
NCI NIH HHS P30 CA014520NEI NIH HHS 1R15EY020816NEI NIH HHS P30 EY016665NEI NIH HHS R01 EY019525NEI NIH HHS R01EY019525NEI NIH HHS R15 EY020816NEI NIH HHS R21 EY023024NEI NIH HHS R24 EY022883NEI NIH HHS RC4 EY021357
6 · The paper itself

Abstract

purposeThe focus of this study was to determine whether bone morphogenetic proteins (BMPs) trigger reactive gliosis in retinal astrocytes and/or Müller glial cells.

methodsRetinal astrocytes and the Müller glial cell line MIO-M1 were treated with vehicle, BMP7, or BMP4. Samples from the treated cells were analyzed for changes in gliosis markers using reverse transcriptase - quantitative PCR (RT-qPCR) and western blotting. To determine potential similarities and differences in gliosis states, control and BMP-treated cells were compared to cells treated with sodium peroxynitrite (a strong oxidizing agent that will bring about some aspects of gliosis). Last, mature mice were microinjected intravitreally with BMP7 and analyzed for changes in gliosis markers using RT-qPCR, western blotting, and immunohistochemistry.

resultsTreatment of retinal astrocyte cells and Müller glial cells with BMP7 regulated various reactive gliosis markers. When compared to the response of cells treated with sodium peroxynitrite, the profiles of gliosis markers regulated due to exposure to BMP7 were similar. However, as expected, the profiles including the oxidative agent and growth factor were not identical. Treatment of cells with BMP4, however, showed an attenuated response in comparison to peroxynitrite and BMP7 treatment. Injection of BMP7 into the mouse retina also triggered a reactive gliosis response 7 days after injection.

conclusionsBMP7 induced changes in levels of mRNA and protein markers typically associated with reactive gliosis in retinal astrocytes and Müller glial cells, including glial fibrillary acidic protein (GFAP), glutamine synthetase (GS), a subset of chondroitin sulfate proteoglycans (CSPGs), matrix metalloproteinases (MMPs), and other molecules.

Indexed as

Activin Receptors, Type IAnimalsAstrocytesBone Morphogenetic Protein 4Bone Morphogenetic Protein 7Bone Morphogenetic Protein Receptors, Type IChondroitin Sulfate ProteoglycansEpendymoglial CellsGlial Fibrillary Acidic ProteinGliosisGlutamate-Ammonia LigaseIntravitreal InjectionsMatrix MetalloproteinasesMiceMice, Inbred C57BLNerve Tissue ProteinsActivin Receptors, Type IAcvr1 protein, mouseBmp4 protein, mousebmp7 protein, mouseBmpr1a protein, mouseBmpr1b protein, mouseBone Morphogenetic Protein 4Bone Morphogenetic Protein 7Bone Morphogenetic Protein Receptors, Type IChondroitin Sulfate ProteoglycansGlial Fibrillary Acidic Proteinglial fibrillary astrocytic protein, mouseGlutamate-Ammonia LigaseMatrix MetalloproteinasesNerve Tissue ProteinsRNA, MessengerSmad ProteinsTransforming Growth Factor beta

Identifiers

PMID25253985
PMCPMC4119236
OpenAlexW1671132205

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.